Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Gross Margin: 2015-2025

Historic Gross Margin for Aytu Biopharma (AYTU) over the last 11 years, with Jun 2025 value amounting to 69.04%.

  • Aytu Biopharma's Gross Margin fell 617.00% to 66.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 67.56%, marking a year-over-year decrease of 751.00%. This contributed to the annual value of 69.04% for FY2025, which is 621.00% down from last year.
  • Aytu Biopharma's Gross Margin amounted to 69.04% in FY2025, which was down 8.26% from 75.26% recorded in FY2024.
  • In the past 5 years, Aytu Biopharma's Gross Margin ranged from a high of 75.26% in FY2024 and a low of 44.49% during FY2021.
  • For the 3-year period, Aytu Biopharma's Gross Margin averaged around 68.78%, with its median value being 69.04% (2025).
  • Its Gross Margin has fluctuated over the past 5 years, first tumbled by 2,554bps in 2021, then surged by 1,321bps in 2024.
  • MRY analysis of 5 years shows Aytu Biopharma's Gross Margin stood at 44.49% in 2021, then grew by 22bps to 54.08% in 2022, then increased by 15bps to 62.04% in 2023, then increased by 21bps to 75.26% in 2024, then dropped by 8bps to 69.04% in 2025.
  • Its last three reported values are 69.04% in FY2025, 75.26% for FY2024, and 62.04% during FY2023.